← Back to Clinical Trials
Recruiting NCT05044273
Evaluation of Effectiveness and Safety of Synergy XD and Synergy Megatron™ Stent
Trial Parameters
Condition Coronary Artery Disease
Sponsor Jung-min Ahn
Study Type OBSERVATIONAL
Phase N/A
Enrollment 2,000
Sex ALL
Min Age 19 Years
Max Age N/A
Start Date 2022-09-01
Completion 2026-12-31
All Conditions
Interventions
Synergy XD stent or Synergy Megatron™ Stent
Brief Summary
The objective of this study is to evaluate the effectiveness and safety of Synergy XD stent and Synergy Megatron™ Stent in the "real world" daily practice as compared with the other drug-eluting stents.
Eligibility Criteria
Inclusion Criteria: * Patients ≥ 19 years old * Patients receiving Synergy XD stent(s) or Synergy Megatron™ stent(s). * The patient or guardian agrees to the study protocol and the schedule of clinical follow-up and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethics Committee of the respective clinical site. Exclusion Criteria: * Patients with a mixture of other drug-eluting stents (DESs) * Terminal illness with life-expectancy ≤1 year. * Patients with cardiogenic shock